| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 Department of Environmental Health, University of Cincinnati, Cincinnati, Ohio and 2 Department of Urology, University of Illinois at Chicago, Chicago, Illinois
Requests for reprints: Gail S. Prins, Department of Urology, University of Illinois at Chicago, 820 South Wood Street, MC 955, Chicago, IL 60612. Phone: 312-413-9766; Fax: 312-996-1291; E-mail: gprins{at}uic.edu.
Early developmental perturbations have been linked to adult-onset prostate pathology, including excessive exposure to estrogenic compounds; however, the molecular basis for this imprinting event is not known. An important and controversial health concern is whether low-dose exposures to hormonally active environmental estrogens, such as bisphenol A, can promote human diseases, including prostate cancer. Here, we show that transient developmental exposure of rats to low, environmentally relevant doses of bisphenol A or estradiol increases prostate gland susceptibility to adult-onset precancerous lesions and hormonal carcinogenesis. We found permanent alterations in the DNA methylation patterns of multiple cell signaling genes, suggesting an epigenetic basis for estrogen imprinting. For phosphodiesterase type 4 variant 4 (PDE4D4), an enzyme responsible for cyclic AMP breakdown, a specific methylation cluster was identified in the 5'-flanking CpG island that was gradually hypermethylated with aging in normal prostates, resulting in loss of gene expression. Early and prolonged hypomethylation at this site following neonatal estradiol or bisphenol A exposure resulted in continued, elevated PDE4D4 expression. Cell line studies confirmed that site-specific methylation is involved in transcriptional silencing of the PDE4D4 gene and showed hypomethylation of this gene in prostate cancer cells. Importantly, the PDE4D4 alterations in the estrogen-exposed prostates were distinguishable before histopathologic changes of the gland, making PDE4D4 a candidate molecular marker for prostate cancer risk assessment as a result of endocrine disruptors. In total, these findings indicate that low-dose exposures to ubiquitous environmental estrogens affect the prostate epigenome during development and, in so doing, promote prostate disease with aging. (Cancer Res 2006; 66(11): 5624-32)
This article has been cited by other articles:
|
|
 |
|
  A. S.L. Cheng, A. C. Culhane, M. W.Y. Chan, C. R. Venkataramu, M. Ehrich, A. Nasir, B. A.T. Rodriguez, J. Liu, P. S. Yan, J. Quackenbush, et al. Epithelial Progeny of Estrogen-Exposed Breast Progenitor Cells Display a Cancer-like Methylome Cancer Res., March 15, 2008; 68(6): 1786 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Benbrahim-Tallaa, B. Siddeek, A. Bozec, V. Tronchon, A. Florin, C. Friry, E. Tabone, C. Mauduit, and M. Benahmed Alterations of Sertoli cell activity in the long-term testicular germ cell death process induced by fetal androgen disruption J. Endocrinol., January 1, 2008; 196(1): 21 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Akingbemi, T. D. Braden, B. W. Kemppainen, K. D. Hancock, J. D. Sherrill, S. J. Cook, X. He, and J. G. Supko Exposure to Phytoestrogens in the Perinatal Period Affects Androgen Secretion by Testicular Leydig Cells in the Adult Rat Endocrinology, September 1, 2007; 148(9): 4475 - 4488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Dolinoy, D. Huang, and R. L. Jirtle Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development PNAS, August 7, 2007; 104(32): 13056 - 13061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Monje, J. Varayoud, E. H Luque, and J. G Ramos Neonatal exposure to bisphenol A modifies the abundance of estrogen receptor {alpha} transcripts with alternative 5'-untranslated regions in the female rat preoptic area J. Endocrinol., July 1, 2007; 194(1): 201 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. S. vom Saal Could hormone residues be involved? Hum. Reprod., June 1, 2007; 22(6): 1503 - 1505. [Full Text] [PDF]
|
|
|
|
 |
|
 H O Goyal, T D Braden, P S Cooke, M A Szewczykowski, C S Williams, P Dalvi, and J W Williams Estrogen receptor-{alpha} mediates estrogen-inducible abnormalities in the developing penis Reproduction, May 1, 2007; 133(5): 1057 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. B. Wetherill, J. K. Hess-Wilson, C. E.S. Comstock, S. A. Shah, C. R. Buncher, L. Sallans, P. A. Limbach, S. Schwemberger, G. F. Babcock, and K. E. Knudsen Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer Mol. Cancer Ther., December 1, 2006; 5(12): 3181 - 3190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-M. HO, Y.-K. LEUNG, and I. CHUNG Estrogens and Antiestrogens as Etiological Factors and Therapeutics for Prostate Cancer Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 177 - 193. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
